BBIO Q1 2020 Earnings — BridgeBio Pharma, Inc. Revenue & Financial Results | Market Cap Arena

BBIOBridgeBio Pharma, Inc.

$14B

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$102M

Net Income

-$92M

EPS (Diluted)

$-0.78

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$84M

Free Cash Flow

-$88M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$990M

Total Liabilities

$538M

Stockholders' Equity

$381M

Cash & Equivalents

$757M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$102M	-$64M	-60.8%
Net Income	-$92M	-$61M	-50.1%